ANG Lifesciences Stock Screener | Share Price & Fundamental Analysis
ANG
Pharmaceuticals
Share Price BSE
₹23.34
▲
0.39 (1.70%)
Track ANG Lifesciences share price live with TickJournal's free stock screener.
Analyze ANG Lifesciences share price history trends and compare 52-week high low
levels.
Calculate ANG stock fair value using fundamental analysis and view live share price charts.
Determine ANG Lifesciences share intrinsic value and compare it with current ANG share price.
Record your ANG Lifesciences trades in TickJournal's free trading journal and track your portfolio performance.
ANG Lifesciences Market Cap
₹38.48 Cr.
ANG P/E Ratio (TTM)
15.00
EPS (TTM)
₹-9.42
Dividend Yield
-
Debt to Equity
1.11
ANG 52 Week High
₹37.81
ANG Lifesciences 52 Week Low
₹21.64
Operating Margin
-4.00%
Profit Margin
-11.11%
ANG Revenue (TTM)
₹18.00
EBITDA
-
Net Income
₹-2.00
Total Assets
₹230.00
Total Equity
₹64.00
ANG Lifesciences Share Price History - Stock Screener Chart
Screen ANG historical share price movements with interactive charts. Analyze price trends and patterns.
ANG Lifesciences Company Profile - Fundamental Screener
Screen ANG Lifesciences company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ANG shares.
Sector
Healthcare
Industry
Pharmaceuticals
Sub-Sector
Pharmaceuticals
Segment
E
ISIN
INE236W01016
ANG Lifesciences Balance Sheet Screener
Screen ANG balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 230 | 242 | 278 | 291 |
| Current Assets | 161 | 173 | 183 | 193 |
| Fixed Assets | 57 | 58 | 88 | 93 |
| Liabilities | ||||
| Total Liabilities | 230 | 242 | 278 | 291 |
| Current Liabilities | 22 | 22 | 29 | 41 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 64 | 76 | 86 | 84 |
| Share Capital | 13 | 13 | 13 | 10 |
| Reserves & Surplus | 46 | 59 | 69 | 69 |
ANG Lifesciences Income Statement Screener - Profit & Revenue Analysis
Screen ANG Lifesciences income statement and profit fundamentals.
Analyze ANG quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for ANG Lifesciences share price evaluation.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18 | 25 | 26 | 38 | 20 | 33 | 25 | 49 | 57 | 34 | 19 | 96 | 74 | 60 | 47 |
| Expenses | 18 | 24 | 26 | 36 | 20 | 31 | 27 | 50 | 50 | 32 | 21 | 83 | 62 | 50 | 44 |
| EBITDA | 0 | 1 | 0 | 2 | 0 | 3 | -2 | -1 | 7 | 2 | -2 | 13 | 12 | 10 | 3 |
| Operating Profit % | -4.00% | 3.00% | 0.00% | 4.00% | -9.00% | 7.00% | -9.00% | -26.00% | 12.00% | 5.00% | -10.00% | 13.00% | 16.00% | 16.00% | 6.00% |
| Depreciation | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 2 |
| Interest | 2 | 2 | 2 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 4 | 3 | 3 | 4 |
| Profit Before Tax | -4 | -3 | -3 | -4 | -4 | -1 | -6 | -6 | 2 | -3 | -6 | 7 | 7 | 4 | -3 |
| Tax | -2 | -1 | 0 | 0 | -1 | 1 | -1 | -1 | 1 | 0 | 0 | 2 | 3 | 2 | -1 |
| Net Profit | -2 | -2 | -3 | -4 | -3 | -2 | -5 | -5 | 2 | -2 | -6 | 5 | 4 | 3 | -2 |
| EPS | -1.56 | -1.52 | -2.24 | -2.75 | -2.35 | -1.53 | -3.98 | -3.63 | 1.41 | -1.74 | -4.52 | 5.16 | 3.99 | 2.20 | -1.36 |
ANG Lifesciences Cash Flow Screener - Liquidity Fundamentals
Screen ANG cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
| Operating Activities | 0 | -10 | 26 | 25 |
| Investing Activities | -2 | 20 | -9 | -44 |
| Financing Activities | 2 | -10 | -17 | 20 |
| Net Cash Flow | 0 | 0 | 0 | 0 |
ANG Lifesciences Shareholding Pattern Screener
See ANG Lifesciences shareholding pattern with promoter, FII, and DII holdings.
Check ANG Lifesciences promoter holding and ownership changes for ANG on TickJournal.
| Item | 2025-Mar | 2025-Jun | 2025-Sept | 2024-Mar | 2024-Jun | 2024-Sept | 2024-Dec | 2023-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 70.60% | 70.60% | 70.60% | 70.60% | 70.60% | 70.60% | 70.60% | 70.60% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 26.11% | 26.11% | 26.18% | 25.62% | 25.48% | 25.45% | 25.92% | 26.13% |
| Other Holding | 3.29% | 3.29% | 3.21% | 3.78% | 3.92% | 3.95% | 3.48% | 3.27% |
| Shareholder Count | 6,508 | 6,400 | 6,273 | 6,868 | 6,631 | 6,468 | 6,517 | 7,163 |
ANG Lifesciences Share Dividend Screener - Share Yield Analysis
Check ANG Lifesciences dividend history with payout and yield data.
View ANG Lifesciences dividend details including ex-dates and amounts for ANG stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹0.00 | 0.00% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹1.00 | 1.33% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
| 2016-March | ₹0.00 | 0.00% |
ANG Lifesciences Stock Index Membership
See which indices include ANG Lifesciences stock.
Check ANG index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
ANG Lifesciences Market Events Screener - Corporate Actions
Get ANG Lifesciences corporate actions including splits, bonuses, and buybacks.
Check ANG Lifesciences stock events that may affect ANG share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -1.68% | ||
| Bonus | 1:1 | - | ||
| Annual General Meeting | NA | -8.62% | ||
| 2025-11-14 | 2025-11-14 | Quarterly Result Announcement | NA | -2.04% |
| 2025-08-14 | 2025-08-14 | Quarterly Result Announcement | NA | -3.93% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -5.27% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -5.83% |
| 2024-11-14 | 2024-11-14 | Quarterly Result Announcement | NA | -4.04% |
| 2022-07-13 | 2022-07-14 | Bonus | 1:4 | 36.04% |
| 2021-11-02 | 2021-11-04 | Dividend | ₹ 1.00 /share | 47.69% |
| 2016-05-18 | 2016-05-18 | Change Of Name | NA | - |
ANG Lifesciences Competitors Screener - Peer Comparison
Screen ANG competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 416,764 | 40.16 | 54,729 | 9.71% | 10,980 | 46.18 |
| Divis Laboratories | 172,462 | 69.16 | 9,712 | 18.67% | 2,191 | 53.62 |
| Torrent Pharmaceuticals | 129,770 | 60.40 | 11,539 | 6.99% | 1,911 | 62.04 |
| Cipla | 120,864 | 22.30 | 28,410 | 7.12% | 5,291 | 44.91 |
| Dr Reddys Laboratories | 105,645 | 18.66 | 33,741 | 16.73% | 5,725 | 60.09 |
| Lupin | 96,238 | 22.21 | 22,910 | 13.74% | 3,306 | 60.88 |
| Zydus Life Science | 92,352 | 18.57 | 23,511 | 18.55% | 4,615 | 47.29 |
| Mankind Pharma | 90,530 | 51.90 | 12,744 | 20.90% | 2,007 | 53.62 |
| Aurobindo Pharma | 70,358 | 20.66 | 32,346 | 9.43% | 3,484 | 57.50 |
| Alkem Laboratories | 66,550 | 27.75 | 13,458 | 3.70% | 2,216 | 47.48 |
ANG Lifesciences Company Announcements - News Screener
Screen ANG latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-10 | Closure of Trading Window | View |
| 2025-11-14 | Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025 | View |
| 2025-11-14 | Board Meeting Outcome for Board Meeting Outcome For To Consider And Approve The Financial Results For The Quarter And Half Year Ended 30-09-2025 | View |
| 2025-11-06 | Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30Th September 2025. | View |
| 2025-10-15 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | View |
| 2025-10-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | View |
| 2025-09-30 | Appoitment Of Secretarial Auditor | View |
| 2025-09-30 | Shareholder Meeting / Postal Ballot-Outcome of AGM | View |
| 2025-09-24 | Closure of Trading Window | View |
| 2025-09-12 | Clarification On Price Movement | View |
| 2025-09-12 | Clarification Sought from ANG Lifesciences India Ltd | - |
| 2025-09-12 | Announcement under Regulation 30 (LODR)-Newspaper Publication | View |
| 2025-09-06 | Reg. 34 (1) Annual Report. | View |
| 2025-09-06 | Notice Of 19Th AGM Of The Company Scheduled To Be Held On 30Th September 2025 | View |
| 2025-09-06 | Intimation Of Book Closure | View |
| 2025-09-06 | 19Th Annual General Meeting (AGM) Of The Shareholders Of The Company Will Be Held On Tuesday The 30Th September 2025 At 11:30 AM Through Video Conference (VC) / Other Audio Visual Means (OAVM) | View |
| 2025-09-06 | Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGM | View |
| 2025-08-14 | Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30.06.2025. | View |
| 2025-08-14 | Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30 2025 | View |
| 2025-08-06 | Board Meeting Intimation for Conducting Board Meeting To Consider And Approve Unaudited Standalone & Consolidated Financial Results For The First Quarter Ended 30Th June 2025. | View |